353277-27-7

Usage

Uses

Used in Pharmaceutical Industry:
6-Chloro-5-nitropyridine-2-carboxylic acid is used as a key intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into complex molecular structures, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 6-Chloro-5-nitropyridine-2-carboxylic acid serves as an essential building block in the creation of compounds designed to protect crops and enhance agricultural productivity, leveraging its reactivity and structural properties.
Used in Dye and Pigment Production:
6-Chloro-5-nitropyridine-2-carboxylic acid is utilized as a precursor in the production of dyes and pigments, where its chemical properties allow for the creation of a diverse range of colorants used in various industries, including textiles, plastics, and printing inks.
Used in Organic Chemistry Research:
As a versatile compound in organic chemistry, 6-Chloro-5-nitropyridine-2-carboxylic acid is employed in research settings to explore new reaction pathways, develop novel synthetic methods, and understand the fundamental principles of chemical reactivity and molecular interactions.

Upstream product

• 21901-29-1 6-amino-5-nitro-2-picoline 
• 39745-39-6 6-methyl-3-nitrohydropyridin-2-one 
• 1824-81-3 2-Amino-6-methylpyridine 
• 56057-19-3 2-chloro-6-methyl-3-nitropyridine 

Downstream Products

• 1260669-90-6 ethyl 6-chloro-5-nitropicolinate 
• 475272-62-9 6-methoxy-5-nitropicolinic acid 
• 84487-06-9 6-amino-5-nitropyridine-2-carboxylic acid 
• 538372-32-6 6-amino-5-nitro-pyridine-2-carboxylic acid methyl ester 
• 475272-63-0 5-nitro-6-phenylmethoxypyridine-2-carboxylic acid 

Relevant academic research and scientific papers

Benzimidazole or azabenzimidazole -6 - carboxylic acid compound and application thereof

The invention discloses benzimidazole or azabenzimidazole -6 - carboxylic acid compound and application thereof, wherein the benzimidazole or azabenzimidazole -6 - carboxylic acid compound has the structure shown in the formula (I). The benzimidazole or a

GLP-1R AGONISTS AND USES THEREOF

Provided herein are compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.

GLP-1 Agonists and Uses Thereof

Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, 7-aza- and 4,7-diaza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS

Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, [formula (I) should be inserted here]. Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods

THE NITROPYRIDINYL ETHYLENEIMINE COMPOUND, THE PHARMACEUTICAL COMPOSITION CONTAINING IT, THE PREPARATION METHOD AND USE THEREOF

The present invention discloses a nitropyridinyl ethyleneimine compound as shown in the formula I and a preparation method of the same, as well as use of the compound in manufacture of a prodrug and in manufacture of a drug for treating a tumor.